JAMA (journal)

November 29, 2022

VUMC’s Anna Person one of the writers of JAMA World AIDS Day article about the end of HIV

doctor checking patient's blood pressure
June 20, 2022

Study finds administering IV fluids during emergency tracheal intubation does not lower cardiac arrest risk

Rapidly administering IV fluids to critically ill adults undergoing emergency tracheal intubation does not significantly decrease chances of hypotension (low blood pressure) and cardiac arrest, a Vanderbilt University Medical Center-led study shows.

December 21, 2021

Study finds apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stroke prevention, reduced bleeding complications

December 15, 2021

Study finds similar success rates with two devices for breathing tube placement

Two devices for placing a breathing tube during critical illness had similar success rates for intubation on the first attempt, according to a study published Dec. 8 in JAMA.

Shichun Bao, MD, PhD, center, and Brenda Weedman, RN, BSN, discuss continuous glucose monitors with patient Sherry Neergaard.
July 15, 2021

Study shows continuous glucose monitors improve management of type 2 diabetes

For patients with type 2 diabetes treated with basal or long-acting insulin, the use of continuous glucose monitors (CGMs) can result in significantly lower hemoglobin A1C (a blood test that reflects average blood glucose levels over three months), and better management of the disease according to a study recently published in the journal JAMA.

May 12, 2021

Heparin, platelets discouraged as treatment for blood clots after COVID vaccine

Heparin and platelets are discouraged as treatment for patients who develop blood clots in the brain and low platelet counts 6-15 days after receiving Johnson & Johnson’s Janssen COVID-19 vaccine, following a clinical investigation review of 12 U.S. cases conducted by the CDC and institutions including Vanderbilt University Medical Center.